SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
0.3521
+0.0078 (2.27%)
At close: May 12, 2025, 4:00 PM
0.3490
-0.0031 (-0.88%)
After-hours: May 12, 2025, 7:06 PM EDT
SciSparc Revenue
In the year 2024, SciSparc had annual revenue of $1.31M, down -54.64%. SciSparc had revenue of $466.00K in the half year ending December 31, 2024, a decrease of -65.40%.
Revenue (ttm)
$1.31M
Revenue Growth
-54.64%
P/S Ratio
1.54
Revenue / Employee
$653,000
Employees
2
Market Cap
3.85M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
SPRC News
- 17 days ago - SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders - GlobeNewsWire
- 2 months ago - SciSparc Signs Definitive Agreement to Sell MitoCareX, Computational Drug Discovery Company Targeting Resistant Cancers - GlobeNewsWire
- 2 months ago - SciSparc Extends $2 Million Loan to Support AutoMax's Growth Following AutoMax's Entry into Direct Import of JAC Electric Vehicles - GlobeNewsWire
- 2 months ago - SciSparc Secures Favorable Settlement in Lawsuit It Filed, Receiving Cash Compensation and a Full Release from All Commitments, Royalties, and Allegations Asserted Against It on Claimed Core Technology - GlobeNewsWire
- 3 months ago - SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico - GlobeNewsWire
- 4 months ago - SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement - GlobeNewsWire
- 4 months ago - SciSparc: AutoMax Enters the Direct Import Market with a $13 Million First Shipment of JAC Electric Vehicles - GlobeNewsWire
- 4 months ago - SciSparc: MitoCareX Bio Expands Research to Pancreatic Cancer Following Initial In-Vitro Positive Results - GlobeNewsWire